nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—VEGFA—stomach cancer	0.209	0.448	CbGaD
Carvedilol—ADRB1—stomach cancer	0.14	0.3	CbGaD
Carvedilol—ADRB2—stomach cancer	0.118	0.252	CbGaD
Carvedilol—XDH—Doxorubicin—stomach cancer	0.0418	0.28	CbGbCtD
Carvedilol—ABCB1—Mitomycin—stomach cancer	0.034	0.227	CbGbCtD
Carvedilol—CYP2C9—Capecitabine—stomach cancer	0.0145	0.0973	CbGbCtD
Carvedilol—CYP1A2—Fluorouracil—stomach cancer	0.00957	0.064	CbGbCtD
Carvedilol—ABCB1—Irinotecan—stomach cancer	0.00872	0.0584	CbGbCtD
Carvedilol—CYP2C9—Fluorouracil—stomach cancer	0.00862	0.0577	CbGbCtD
Carvedilol—SELE—vein—stomach cancer	0.00825	0.0852	CbGeAlD
Carvedilol—VCAM1—vein—stomach cancer	0.00759	0.0784	CbGeAlD
Carvedilol—ABCB1—Docetaxel—stomach cancer	0.00639	0.0428	CbGbCtD
Carvedilol—CYP3A4—Irinotecan—stomach cancer	0.00522	0.035	CbGbCtD
Carvedilol—ABCB1—Doxorubicin—stomach cancer	0.00476	0.0319	CbGbCtD
Carvedilol—ABCB1—Methotrexate—stomach cancer	0.00461	0.0309	CbGbCtD
Carvedilol—CYP2D6—Doxorubicin—stomach cancer	0.00449	0.03	CbGbCtD
Carvedilol—NPPB—blood vessel—stomach cancer	0.00388	0.04	CbGeAlD
Carvedilol—CYP3A4—Docetaxel—stomach cancer	0.00383	0.0256	CbGbCtD
Carvedilol—CYP3A4—Doxorubicin—stomach cancer	0.00285	0.0191	CbGbCtD
Carvedilol—SELE—blood vessel—stomach cancer	0.00262	0.027	CbGeAlD
Carvedilol—VCAM1—blood vessel—stomach cancer	0.00241	0.0249	CbGeAlD
Carvedilol—HIF1A—blood vessel—stomach cancer	0.00232	0.0239	CbGeAlD
Carvedilol—GJA1—blood vessel—stomach cancer	0.00225	0.0232	CbGeAlD
Carvedilol—HIF1A—gall bladder—stomach cancer	0.00218	0.0225	CbGeAlD
Carvedilol—NPPB—hematopoietic system—stomach cancer	0.00206	0.0213	CbGeAlD
Carvedilol—NPPB—smooth muscle tissue—stomach cancer	0.00182	0.0188	CbGeAlD
Carvedilol—NPPB—pancreas—stomach cancer	0.00168	0.0174	CbGeAlD
Carvedilol—Methocarbamol—CA1—stomach cancer	0.00154	0.347	CrCbGaD
Carvedilol—NPPB—lymphoid tissue—stomach cancer	0.00145	0.015	CbGeAlD
Carvedilol—SELE—hematopoietic system—stomach cancer	0.00139	0.0144	CbGeAlD
Carvedilol—VCAM1—hematopoietic system—stomach cancer	0.00128	0.0132	CbGeAlD
Carvedilol—SELE—epithelium—stomach cancer	0.00127	0.0132	CbGeAlD
Carvedilol—HIF1A—hematopoietic system—stomach cancer	0.00123	0.0127	CbGeAlD
Carvedilol—SELE—smooth muscle tissue—stomach cancer	0.00123	0.0127	CbGeAlD
Carvedilol—GJA1—hematopoietic system—stomach cancer	0.0012	0.0124	CbGeAlD
Carvedilol—NPPB—endocrine gland—stomach cancer	0.00119	0.0122	CbGeAlD
Carvedilol—VCAM1—epithelium—stomach cancer	0.00117	0.0121	CbGeAlD
Carvedilol—VCAM1—smooth muscle tissue—stomach cancer	0.00113	0.0117	CbGeAlD
Carvedilol—HIF1A—epithelium—stomach cancer	0.00113	0.0116	CbGeAlD
Carvedilol—GJA1—epithelium—stomach cancer	0.00109	0.0113	CbGeAlD
Carvedilol—HIF1A—smooth muscle tissue—stomach cancer	0.00109	0.0112	CbGeAlD
Carvedilol—GJA1—smooth muscle tissue—stomach cancer	0.00105	0.0109	CbGeAlD
Carvedilol—VCAM1—pancreas—stomach cancer	0.00104	0.0108	CbGeAlD
Carvedilol—NDUFC2—hematopoietic system—stomach cancer	0.00104	0.0108	CbGeAlD
Carvedilol—HIF1A—pancreas—stomach cancer	0.001	0.0104	CbGeAlD
Carvedilol—SELE—lymphoid tissue—stomach cancer	0.000982	0.0101	CbGeAlD
Carvedilol—GJA1—pancreas—stomach cancer	0.000975	0.0101	CbGeAlD
Carvedilol—SELE—digestive system—stomach cancer	0.00097	0.01	CbGeAlD
Carvedilol—NDUFC2—epithelium—stomach cancer	0.000953	0.00983	CbGeAlD
Carvedilol—VCAM1—lymphoid tissue—stomach cancer	0.000903	0.00932	CbGeAlD
Carvedilol—VCAM1—digestive system—stomach cancer	0.000892	0.00921	CbGeAlD
Carvedilol—HIF1A—lymphoid tissue—stomach cancer	0.000869	0.00897	CbGeAlD
Carvedilol—HIF1A—digestive system—stomach cancer	0.000858	0.00886	CbGeAlD
Carvedilol—GJA1—lymphoid tissue—stomach cancer	0.000843	0.0087	CbGeAlD
Carvedilol—VEGFA—smooth muscle tissue—stomach cancer	0.000833	0.0086	CbGeAlD
Carvedilol—GJA1—digestive system—stomach cancer	0.000833	0.0086	CbGeAlD
Carvedilol—VCAM1—bone marrow—stomach cancer	0.000822	0.00849	CbGeAlD
Carvedilol—SELE—endocrine gland—stomach cancer	0.000801	0.00827	CbGeAlD
Carvedilol—HIF1A—bone marrow—stomach cancer	0.000791	0.00817	CbGeAlD
Carvedilol—VEGFA—pancreas—stomach cancer	0.00077	0.00795	CbGeAlD
Carvedilol—GJA1—bone marrow—stomach cancer	0.000767	0.00792	CbGeAlD
Carvedilol—VCAM1—endocrine gland—stomach cancer	0.000737	0.00761	CbGeAlD
Carvedilol—NDUFC2—lymphoid tissue—stomach cancer	0.000734	0.00757	CbGeAlD
Carvedilol—NDUFC2—digestive system—stomach cancer	0.000725	0.00748	CbGeAlD
Carvedilol—SELE—liver—stomach cancer	0.000722	0.00746	CbGeAlD
Carvedilol—HIF1A—endocrine gland—stomach cancer	0.000709	0.00732	CbGeAlD
Carvedilol—GJA1—endocrine gland—stomach cancer	0.000688	0.0071	CbGeAlD
Carvedilol—NDUFC2—bone marrow—stomach cancer	0.000668	0.0069	CbGeAlD
Carvedilol—VCAM1—liver—stomach cancer	0.000665	0.00686	CbGeAlD
Carvedilol—HIF1A—liver—stomach cancer	0.000639	0.0066	CbGeAlD
Carvedilol—GJA1—liver—stomach cancer	0.00062	0.0064	CbGeAlD
Carvedilol—VEGFA—bone marrow—stomach cancer	0.000606	0.00626	CbGeAlD
Carvedilol—NDUFC2—endocrine gland—stomach cancer	0.000599	0.00618	CbGeAlD
Carvedilol—XDH—digestive system—stomach cancer	0.000585	0.00604	CbGeAlD
Carvedilol—ADRA1D—epithelium—stomach cancer	0.000565	0.00583	CbGeAlD
Carvedilol—SELE—lymph node—stomach cancer	0.000554	0.00572	CbGeAlD
Carvedilol—NDUFC2—liver—stomach cancer	0.00054	0.00557	CbGeAlD
Carvedilol—VCAM1—lymph node—stomach cancer	0.00051	0.00526	CbGeAlD
Carvedilol—HIF1A—lymph node—stomach cancer	0.00049	0.00506	CbGeAlD
Carvedilol—VEGFA—liver—stomach cancer	0.00049	0.00506	CbGeAlD
Carvedilol—XDH—endocrine gland—stomach cancer	0.000484	0.00499	CbGeAlD
Carvedilol—PTGS1—blood vessel—stomach cancer	0.000477	0.00493	CbGeAlD
Carvedilol—GJA1—lymph node—stomach cancer	0.000476	0.00491	CbGeAlD
Carvedilol—XDH—liver—stomach cancer	0.000436	0.0045	CbGeAlD
Carvedilol—Bevantolol—ADRB1—stomach cancer	0.000436	0.0985	CrCbGaD
Carvedilol—NDUFC2—lymph node—stomach cancer	0.000414	0.00427	CbGeAlD
Carvedilol—Bopindolol—ADRB1—stomach cancer	0.000403	0.0912	CrCbGaD
Carvedilol—VEGFA—lymph node—stomach cancer	0.000376	0.00388	CbGeAlD
Carvedilol—Bevantolol—ADRB2—stomach cancer	0.000366	0.0828	CrCbGaD
Carvedilol—Bopindolol—HTR1A—stomach cancer	0.000361	0.0816	CrCbGaD
Carvedilol—ADRA1D—endocrine gland—stomach cancer	0.000355	0.00366	CbGeAlD
Carvedilol—ADRA1A—hematopoietic system—stomach cancer	0.000355	0.00366	CbGeAlD
Carvedilol—Tamsulosin—HTR1A—stomach cancer	0.000347	0.0786	CrCbGaD
Carvedilol—KCNH2—hematopoietic system—stomach cancer	0.000343	0.00354	CbGeAlD
Carvedilol—Bopindolol—ADRB2—stomach cancer	0.000339	0.0767	CrCbGaD
Carvedilol—ADRA1A—epithelium—stomach cancer	0.000324	0.00335	CbGeAlD
Carvedilol—CYP1A2—hematopoietic system—stomach cancer	0.000293	0.00303	CbGeAlD
Carvedilol—CYP1A1—hematopoietic system—stomach cancer	0.000289	0.00299	CbGeAlD
Carvedilol—ABCB1—blood vessel—stomach cancer	0.000282	0.00291	CbGeAlD
Carvedilol—CYP2C9—hematopoietic system—stomach cancer	0.000278	0.00287	CbGeAlD
Carvedilol—ADRA2C—pancreas—stomach cancer	0.000275	0.00284	CbGeAlD
Carvedilol—ADRA2A—hematopoietic system—stomach cancer	0.00027	0.00278	CbGeAlD
Carvedilol—CYP1A1—epithelium—stomach cancer	0.000264	0.00273	CbGeAlD
Carvedilol—CYP2E1—hematopoietic system—stomach cancer	0.000264	0.00272	CbGeAlD
Carvedilol—ADRB1—endocrine gland—stomach cancer	0.000258	0.00266	CbGeAlD
Carvedilol—PTGS1—hematopoietic system—stomach cancer	0.000254	0.00262	CbGeAlD
Carvedilol—ADRA1A—lymphoid tissue—stomach cancer	0.00025	0.00258	CbGeAlD
Carvedilol—PTGS1—epithelium—stomach cancer	0.000232	0.0024	CbGeAlD
Carvedilol—PTGS1—smooth muscle tissue—stomach cancer	0.000224	0.00231	CbGeAlD
Carvedilol—Propafenone—ADRB1—stomach cancer	0.000221	0.05	CrCbGaD
Carvedilol—KCNH2—bone marrow—stomach cancer	0.00022	0.00227	CbGeAlD
Carvedilol—ADRA2A—pancreas—stomach cancer	0.00022	0.00227	CbGeAlD
Carvedilol—CYP3A4—hematopoietic system—stomach cancer	0.000212	0.00219	CbGeAlD
Carvedilol—CYP2D6—hematopoietic system—stomach cancer	0.000209	0.00216	CbGeAlD
Carvedilol—CYP1A2—digestive system—stomach cancer	0.000204	0.00211	CbGeAlD
Carvedilol—ADRA1A—endocrine gland—stomach cancer	0.000204	0.0021	CbGeAlD
Carvedilol—CYP1A1—digestive system—stomach cancer	0.000201	0.00208	CbGeAlD
Carvedilol—KCNH2—endocrine gland—stomach cancer	0.000197	0.00203	CbGeAlD
Carvedilol—CYP2C9—digestive system—stomach cancer	0.000194	0.002	CbGeAlD
Carvedilol—CYP2E1—lymphoid tissue—stomach cancer	0.000186	0.00192	CbGeAlD
Carvedilol—ADRA1A—liver—stomach cancer	0.000184	0.0019	CbGeAlD
Carvedilol—CYP2E1—digestive system—stomach cancer	0.000183	0.00189	CbGeAlD
Carvedilol—PTGS1—digestive system—stomach cancer	0.000177	0.00182	CbGeAlD
Carvedilol—ADRA2C—liver—stomach cancer	0.000175	0.00181	CbGeAlD
Carvedilol—CYP1A2—endocrine gland—stomach cancer	0.000169	0.00174	CbGeAlD
Carvedilol—CYP1A1—endocrine gland—stomach cancer	0.000166	0.00172	CbGeAlD
Carvedilol—CYP2C9—endocrine gland—stomach cancer	0.00016	0.00165	CbGeAlD
Carvedilol—ADRA2A—endocrine gland—stomach cancer	0.000155	0.0016	CbGeAlD
Carvedilol—CYP1A2—liver—stomach cancer	0.000152	0.00157	CbGeAlD
Carvedilol—CYP2E1—endocrine gland—stomach cancer	0.000152	0.00157	CbGeAlD
Carvedilol—Propranolol—ADRB1—stomach cancer	0.000151	0.0342	CrCbGaD
Carvedilol—ABCB1—hematopoietic system—stomach cancer	0.00015	0.00155	CbGeAlD
Carvedilol—CYP1A1—liver—stomach cancer	0.00015	0.00155	CbGeAlD
Carvedilol—CYP3A4—digestive system—stomach cancer	0.000148	0.00152	CbGeAlD
Carvedilol—PTGS1—endocrine gland—stomach cancer	0.000146	0.00151	CbGeAlD
Carvedilol—CYP2D6—digestive system—stomach cancer	0.000145	0.0015	CbGeAlD
Carvedilol—CYP2C9—liver—stomach cancer	0.000144	0.00149	CbGeAlD
Carvedilol—ABCB1—epithelium—stomach cancer	0.000137	0.00142	CbGeAlD
Carvedilol—CYP2E1—liver—stomach cancer	0.000137	0.00141	CbGeAlD
Carvedilol—KCNH2—lymph node—stomach cancer	0.000136	0.0014	CbGeAlD
Carvedilol—Propranolol—HTR1A—stomach cancer	0.000135	0.0306	CrCbGaD
Carvedilol—ADRA2C—lymph node—stomach cancer	0.000134	0.00139	CbGeAlD
Carvedilol—Propranolol—ADRB2—stomach cancer	0.000127	0.0288	CrCbGaD
Carvedilol—ABCB1—pancreas—stomach cancer	0.000122	0.00126	CbGeAlD
Carvedilol—CYP3A4—endocrine gland—stomach cancer	0.000122	0.00126	CbGeAlD
Carvedilol—CYP2D6—endocrine gland—stomach cancer	0.00012	0.00124	CbGeAlD
Carvedilol—CYP1A1—lymph node—stomach cancer	0.000115	0.00119	CbGeAlD
Carvedilol—CYP3A4—liver—stomach cancer	0.00011	0.00114	CbGeAlD
Carvedilol—CYP2D6—liver—stomach cancer	0.000108	0.00112	CbGeAlD
Carvedilol—ADRA2A—lymph node—stomach cancer	0.000107	0.00111	CbGeAlD
Carvedilol—ABCB1—lymphoid tissue—stomach cancer	0.000106	0.00109	CbGeAlD
Carvedilol—ABCB1—digestive system—stomach cancer	0.000105	0.00108	CbGeAlD
Carvedilol—PTGS1—lymph node—stomach cancer	0.000101	0.00104	CbGeAlD
Carvedilol—ABCB1—bone marrow—stomach cancer	9.63e-05	0.000995	CbGeAlD
Carvedilol—ABCB1—endocrine gland—stomach cancer	8.64e-05	0.000892	CbGeAlD
Carvedilol—ABCB1—liver—stomach cancer	7.79e-05	0.000804	CbGeAlD
Carvedilol—Headache—Irinotecan—stomach cancer	7.39e-05	0.000569	CcSEcCtD
Carvedilol—Hypotension—Capecitabine—stomach cancer	7.38e-05	0.000568	CcSEcCtD
Carvedilol—Insomnia—Docetaxel—stomach cancer	7.37e-05	0.000568	CcSEcCtD
Carvedilol—Paraesthesia—Docetaxel—stomach cancer	7.32e-05	0.000564	CcSEcCtD
Carvedilol—Erythema multiforme—Epirubicin—stomach cancer	7.32e-05	0.000563	CcSEcCtD
Carvedilol—Alopecia—Methotrexate—stomach cancer	7.31e-05	0.000563	CcSEcCtD
Carvedilol—Bradycardia—Doxorubicin—stomach cancer	7.29e-05	0.000561	CcSEcCtD
Carvedilol—Dyspnoea—Docetaxel—stomach cancer	7.27e-05	0.00056	CcSEcCtD
Carvedilol—Somnolence—Docetaxel—stomach cancer	7.25e-05	0.000558	CcSEcCtD
Carvedilol—Tinnitus—Epirubicin—stomach cancer	7.22e-05	0.000556	CcSEcCtD
Carvedilol—Malnutrition—Methotrexate—stomach cancer	7.2e-05	0.000554	CcSEcCtD
Carvedilol—Haemoglobin—Doxorubicin—stomach cancer	7.2e-05	0.000554	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Capecitabine—stomach cancer	7.19e-05	0.000554	CcSEcCtD
Carvedilol—Vomiting—Fluorouracil—stomach cancer	7.18e-05	0.000553	CcSEcCtD
Carvedilol—Rhinitis—Doxorubicin—stomach cancer	7.18e-05	0.000553	CcSEcCtD
Carvedilol—Dyspepsia—Docetaxel—stomach cancer	7.18e-05	0.000552	CcSEcCtD
Carvedilol—Haemorrhage—Doxorubicin—stomach cancer	7.16e-05	0.000551	CcSEcCtD
Carvedilol—Insomnia—Capecitabine—stomach cancer	7.14e-05	0.00055	CcSEcCtD
Carvedilol—Hypoaesthesia—Doxorubicin—stomach cancer	7.13e-05	0.000549	CcSEcCtD
Carvedilol—Rash—Fluorouracil—stomach cancer	7.12e-05	0.000548	CcSEcCtD
Carvedilol—Dermatitis—Fluorouracil—stomach cancer	7.12e-05	0.000548	CcSEcCtD
Carvedilol—Pharyngitis—Doxorubicin—stomach cancer	7.11e-05	0.000547	CcSEcCtD
Carvedilol—Paraesthesia—Capecitabine—stomach cancer	7.09e-05	0.000546	CcSEcCtD
Carvedilol—Decreased appetite—Docetaxel—stomach cancer	7.09e-05	0.000546	CcSEcCtD
Carvedilol—Headache—Fluorouracil—stomach cancer	7.08e-05	0.000545	CcSEcCtD
Carvedilol—Urinary tract disorder—Doxorubicin—stomach cancer	7.07e-05	0.000544	CcSEcCtD
Carvedilol—Oedema peripheral—Doxorubicin—stomach cancer	7.06e-05	0.000543	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Docetaxel—stomach cancer	7.04e-05	0.000542	CcSEcCtD
Carvedilol—Dyspnoea—Capecitabine—stomach cancer	7.04e-05	0.000542	CcSEcCtD
Carvedilol—Fatigue—Docetaxel—stomach cancer	7.03e-05	0.000541	CcSEcCtD
Carvedilol—Angiopathy—Epirubicin—stomach cancer	7.02e-05	0.000541	CcSEcCtD
Carvedilol—Urethral disorder—Doxorubicin—stomach cancer	7.02e-05	0.00054	CcSEcCtD
Carvedilol—Nausea—Irinotecan—stomach cancer	7.01e-05	0.000539	CcSEcCtD
Carvedilol—Immune system disorder—Epirubicin—stomach cancer	6.99e-05	0.000538	CcSEcCtD
Carvedilol—Mediastinal disorder—Epirubicin—stomach cancer	6.98e-05	0.000537	CcSEcCtD
Carvedilol—Constipation—Docetaxel—stomach cancer	6.97e-05	0.000537	CcSEcCtD
Carvedilol—Pain—Docetaxel—stomach cancer	6.97e-05	0.000537	CcSEcCtD
Carvedilol—Back pain—Methotrexate—stomach cancer	6.97e-05	0.000536	CcSEcCtD
Carvedilol—Dyspepsia—Capecitabine—stomach cancer	6.95e-05	0.000535	CcSEcCtD
Carvedilol—Visual impairment—Doxorubicin—stomach cancer	6.9e-05	0.000531	CcSEcCtD
Carvedilol—Decreased appetite—Capecitabine—stomach cancer	6.86e-05	0.000528	CcSEcCtD
Carvedilol—Alopecia—Epirubicin—stomach cancer	6.84e-05	0.000527	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Capecitabine—stomach cancer	6.82e-05	0.000525	CcSEcCtD
Carvedilol—Fatigue—Capecitabine—stomach cancer	6.81e-05	0.000524	CcSEcCtD
Carvedilol—Vision blurred—Methotrexate—stomach cancer	6.79e-05	0.000522	CcSEcCtD
Carvedilol—Erythema multiforme—Doxorubicin—stomach cancer	6.77e-05	0.000521	CcSEcCtD
Carvedilol—Pain—Capecitabine—stomach cancer	6.75e-05	0.00052	CcSEcCtD
Carvedilol—Constipation—Capecitabine—stomach cancer	6.75e-05	0.00052	CcSEcCtD
Carvedilol—Malnutrition—Epirubicin—stomach cancer	6.74e-05	0.000519	CcSEcCtD
Carvedilol—Feeling abnormal—Docetaxel—stomach cancer	6.72e-05	0.000517	CcSEcCtD
Carvedilol—Nausea—Fluorouracil—stomach cancer	6.71e-05	0.000516	CcSEcCtD
Carvedilol—Ill-defined disorder—Methotrexate—stomach cancer	6.68e-05	0.000514	CcSEcCtD
Carvedilol—Tinnitus—Doxorubicin—stomach cancer	6.68e-05	0.000514	CcSEcCtD
Carvedilol—Gastrointestinal pain—Docetaxel—stomach cancer	6.67e-05	0.000513	CcSEcCtD
Carvedilol—Anaemia—Methotrexate—stomach cancer	6.66e-05	0.000512	CcSEcCtD
Carvedilol—Flatulence—Epirubicin—stomach cancer	6.64e-05	0.000511	CcSEcCtD
Carvedilol—Tension—Epirubicin—stomach cancer	6.61e-05	0.000509	CcSEcCtD
Carvedilol—Nervousness—Epirubicin—stomach cancer	6.54e-05	0.000504	CcSEcCtD
Carvedilol—Back pain—Epirubicin—stomach cancer	6.52e-05	0.000502	CcSEcCtD
Carvedilol—Feeling abnormal—Capecitabine—stomach cancer	6.51e-05	0.000501	CcSEcCtD
Carvedilol—Angiopathy—Doxorubicin—stomach cancer	6.5e-05	0.0005	CcSEcCtD
Carvedilol—Malaise—Methotrexate—stomach cancer	6.49e-05	0.0005	CcSEcCtD
Carvedilol—Muscle spasms—Epirubicin—stomach cancer	6.48e-05	0.000499	CcSEcCtD
Carvedilol—Immune system disorder—Doxorubicin—stomach cancer	6.47e-05	0.000498	CcSEcCtD
Carvedilol—Vertigo—Methotrexate—stomach cancer	6.47e-05	0.000498	CcSEcCtD
Carvedilol—Gastrointestinal pain—Capecitabine—stomach cancer	6.46e-05	0.000497	CcSEcCtD
Carvedilol—Mediastinal disorder—Doxorubicin—stomach cancer	6.46e-05	0.000497	CcSEcCtD
Carvedilol—Abdominal pain—Docetaxel—stomach cancer	6.45e-05	0.000496	CcSEcCtD
Carvedilol—Body temperature increased—Docetaxel—stomach cancer	6.45e-05	0.000496	CcSEcCtD
Carvedilol—Leukopenia—Methotrexate—stomach cancer	6.45e-05	0.000496	CcSEcCtD
Carvedilol—Vision blurred—Epirubicin—stomach cancer	6.35e-05	0.000489	CcSEcCtD
Carvedilol—Alopecia—Doxorubicin—stomach cancer	6.33e-05	0.000487	CcSEcCtD
Carvedilol—Cough—Methotrexate—stomach cancer	6.28e-05	0.000484	CcSEcCtD
Carvedilol—Urticaria—Capecitabine—stomach cancer	6.27e-05	0.000483	CcSEcCtD
Carvedilol—Ill-defined disorder—Epirubicin—stomach cancer	6.25e-05	0.000481	CcSEcCtD
Carvedilol—Body temperature increased—Capecitabine—stomach cancer	6.24e-05	0.00048	CcSEcCtD
Carvedilol—Abdominal pain—Capecitabine—stomach cancer	6.24e-05	0.00048	CcSEcCtD
Carvedilol—Convulsion—Methotrexate—stomach cancer	6.24e-05	0.00048	CcSEcCtD
Carvedilol—Malnutrition—Doxorubicin—stomach cancer	6.24e-05	0.00048	CcSEcCtD
Carvedilol—Anaemia—Epirubicin—stomach cancer	6.23e-05	0.000479	CcSEcCtD
Carvedilol—Flatulence—Doxorubicin—stomach cancer	6.14e-05	0.000473	CcSEcCtD
Carvedilol—Myalgia—Methotrexate—stomach cancer	6.13e-05	0.000472	CcSEcCtD
Carvedilol—Chest pain—Methotrexate—stomach cancer	6.13e-05	0.000472	CcSEcCtD
Carvedilol—Arthralgia—Methotrexate—stomach cancer	6.13e-05	0.000472	CcSEcCtD
Carvedilol—Tension—Doxorubicin—stomach cancer	6.12e-05	0.000471	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	6.09e-05	0.000469	CcSEcCtD
Carvedilol—Malaise—Epirubicin—stomach cancer	6.08e-05	0.000468	CcSEcCtD
Carvedilol—Discomfort—Methotrexate—stomach cancer	6.06e-05	0.000466	CcSEcCtD
Carvedilol—Nervousness—Doxorubicin—stomach cancer	6.06e-05	0.000466	CcSEcCtD
Carvedilol—Vertigo—Epirubicin—stomach cancer	6.05e-05	0.000466	CcSEcCtD
Carvedilol—Syncope—Epirubicin—stomach cancer	6.04e-05	0.000465	CcSEcCtD
Carvedilol—Leukopenia—Epirubicin—stomach cancer	6.03e-05	0.000464	CcSEcCtD
Carvedilol—Back pain—Doxorubicin—stomach cancer	6.03e-05	0.000464	CcSEcCtD
Carvedilol—Hypersensitivity—Docetaxel—stomach cancer	6.01e-05	0.000462	CcSEcCtD
Carvedilol—Muscle spasms—Doxorubicin—stomach cancer	5.99e-05	0.000461	CcSEcCtD
Carvedilol—ABCB1—lymph node—stomach cancer	5.97e-05	0.000616	CbGeAlD
Carvedilol—Palpitations—Epirubicin—stomach cancer	5.96e-05	0.000458	CcSEcCtD
Carvedilol—Confusional state—Methotrexate—stomach cancer	5.93e-05	0.000456	CcSEcCtD
Carvedilol—Loss of consciousness—Epirubicin—stomach cancer	5.92e-05	0.000456	CcSEcCtD
Carvedilol—Cough—Epirubicin—stomach cancer	5.88e-05	0.000453	CcSEcCtD
Carvedilol—Anaphylactic shock—Methotrexate—stomach cancer	5.88e-05	0.000452	CcSEcCtD
Carvedilol—Vision blurred—Doxorubicin—stomach cancer	5.88e-05	0.000452	CcSEcCtD
Carvedilol—Asthenia—Docetaxel—stomach cancer	5.85e-05	0.00045	CcSEcCtD
Carvedilol—Convulsion—Epirubicin—stomach cancer	5.84e-05	0.000449	CcSEcCtD
Carvedilol—Infection—Methotrexate—stomach cancer	5.84e-05	0.000449	CcSEcCtD
Carvedilol—Hypertension—Epirubicin—stomach cancer	5.82e-05	0.000448	CcSEcCtD
Carvedilol—Hypersensitivity—Capecitabine—stomach cancer	5.82e-05	0.000448	CcSEcCtD
Carvedilol—Ill-defined disorder—Doxorubicin—stomach cancer	5.79e-05	0.000445	CcSEcCtD
Carvedilol—Pruritus—Docetaxel—stomach cancer	5.77e-05	0.000444	CcSEcCtD
Carvedilol—Anaemia—Doxorubicin—stomach cancer	5.76e-05	0.000444	CcSEcCtD
Carvedilol—Thrombocytopenia—Methotrexate—stomach cancer	5.75e-05	0.000443	CcSEcCtD
Carvedilol—Arthralgia—Epirubicin—stomach cancer	5.74e-05	0.000442	CcSEcCtD
Carvedilol—Chest pain—Epirubicin—stomach cancer	5.74e-05	0.000442	CcSEcCtD
Carvedilol—Myalgia—Epirubicin—stomach cancer	5.74e-05	0.000442	CcSEcCtD
Carvedilol—Skin disorder—Methotrexate—stomach cancer	5.71e-05	0.000439	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	5.7e-05	0.000439	CcSEcCtD
Carvedilol—Hyperhidrosis—Methotrexate—stomach cancer	5.68e-05	0.000437	CcSEcCtD
Carvedilol—Discomfort—Epirubicin—stomach cancer	5.67e-05	0.000436	CcSEcCtD
Carvedilol—Asthenia—Capecitabine—stomach cancer	5.66e-05	0.000436	CcSEcCtD
Carvedilol—Malaise—Doxorubicin—stomach cancer	5.62e-05	0.000433	CcSEcCtD
Carvedilol—Dry mouth—Epirubicin—stomach cancer	5.61e-05	0.000432	CcSEcCtD
Carvedilol—Vertigo—Doxorubicin—stomach cancer	5.6e-05	0.000431	CcSEcCtD
Carvedilol—Anorexia—Methotrexate—stomach cancer	5.6e-05	0.000431	CcSEcCtD
Carvedilol—Syncope—Doxorubicin—stomach cancer	5.59e-05	0.00043	CcSEcCtD
Carvedilol—Pruritus—Capecitabine—stomach cancer	5.59e-05	0.00043	CcSEcCtD
Carvedilol—Leukopenia—Doxorubicin—stomach cancer	5.58e-05	0.00043	CcSEcCtD
Carvedilol—Diarrhoea—Docetaxel—stomach cancer	5.58e-05	0.000429	CcSEcCtD
Carvedilol—Confusional state—Epirubicin—stomach cancer	5.55e-05	0.000427	CcSEcCtD
Carvedilol—Palpitations—Doxorubicin—stomach cancer	5.51e-05	0.000424	CcSEcCtD
Carvedilol—Oedema—Epirubicin—stomach cancer	5.5e-05	0.000423	CcSEcCtD
Carvedilol—Anaphylactic shock—Epirubicin—stomach cancer	5.5e-05	0.000423	CcSEcCtD
Carvedilol—Hypotension—Methotrexate—stomach cancer	5.49e-05	0.000423	CcSEcCtD
Carvedilol—Loss of consciousness—Doxorubicin—stomach cancer	5.48e-05	0.000422	CcSEcCtD
Carvedilol—Infection—Epirubicin—stomach cancer	5.46e-05	0.000421	CcSEcCtD
Carvedilol—Cough—Doxorubicin—stomach cancer	5.44e-05	0.000419	CcSEcCtD
Carvedilol—Shock—Epirubicin—stomach cancer	5.41e-05	0.000416	CcSEcCtD
Carvedilol—Convulsion—Doxorubicin—stomach cancer	5.4e-05	0.000416	CcSEcCtD
Carvedilol—Diarrhoea—Capecitabine—stomach cancer	5.4e-05	0.000416	CcSEcCtD
Carvedilol—Dizziness—Docetaxel—stomach cancer	5.39e-05	0.000415	CcSEcCtD
Carvedilol—Thrombocytopenia—Epirubicin—stomach cancer	5.38e-05	0.000414	CcSEcCtD
Carvedilol—Hypertension—Doxorubicin—stomach cancer	5.38e-05	0.000414	CcSEcCtD
Carvedilol—Tachycardia—Epirubicin—stomach cancer	5.37e-05	0.000413	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Methotrexate—stomach cancer	5.35e-05	0.000412	CcSEcCtD
Carvedilol—Skin disorder—Epirubicin—stomach cancer	5.34e-05	0.000411	CcSEcCtD
Carvedilol—Hyperhidrosis—Epirubicin—stomach cancer	5.32e-05	0.000409	CcSEcCtD
Carvedilol—Insomnia—Methotrexate—stomach cancer	5.32e-05	0.000409	CcSEcCtD
Carvedilol—Myalgia—Doxorubicin—stomach cancer	5.31e-05	0.000409	CcSEcCtD
Carvedilol—Arthralgia—Doxorubicin—stomach cancer	5.31e-05	0.000409	CcSEcCtD
Carvedilol—Chest pain—Doxorubicin—stomach cancer	5.31e-05	0.000409	CcSEcCtD
Carvedilol—Paraesthesia—Methotrexate—stomach cancer	5.28e-05	0.000406	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	5.27e-05	0.000406	CcSEcCtD
Carvedilol—Discomfort—Doxorubicin—stomach cancer	5.24e-05	0.000404	CcSEcCtD
Carvedilol—Anorexia—Epirubicin—stomach cancer	5.24e-05	0.000404	CcSEcCtD
Carvedilol—Dyspnoea—Methotrexate—stomach cancer	5.24e-05	0.000403	CcSEcCtD
Carvedilol—Somnolence—Methotrexate—stomach cancer	5.22e-05	0.000402	CcSEcCtD
Carvedilol—Dizziness—Capecitabine—stomach cancer	5.22e-05	0.000402	CcSEcCtD
Carvedilol—Dry mouth—Doxorubicin—stomach cancer	5.19e-05	0.0004	CcSEcCtD
Carvedilol—Vomiting—Docetaxel—stomach cancer	5.18e-05	0.000399	CcSEcCtD
Carvedilol—Dyspepsia—Methotrexate—stomach cancer	5.17e-05	0.000398	CcSEcCtD
Carvedilol—Rash—Docetaxel—stomach cancer	5.14e-05	0.000396	CcSEcCtD
Carvedilol—Hypotension—Epirubicin—stomach cancer	5.14e-05	0.000396	CcSEcCtD
Carvedilol—Dermatitis—Docetaxel—stomach cancer	5.14e-05	0.000395	CcSEcCtD
Carvedilol—Confusional state—Doxorubicin—stomach cancer	5.13e-05	0.000395	CcSEcCtD
Carvedilol—Decreased appetite—Methotrexate—stomach cancer	5.11e-05	0.000393	CcSEcCtD
Carvedilol—Headache—Docetaxel—stomach cancer	5.11e-05	0.000393	CcSEcCtD
Carvedilol—Oedema—Doxorubicin—stomach cancer	5.09e-05	0.000392	CcSEcCtD
Carvedilol—Anaphylactic shock—Doxorubicin—stomach cancer	5.09e-05	0.000392	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Methotrexate—stomach cancer	5.07e-05	0.000391	CcSEcCtD
Carvedilol—Fatigue—Methotrexate—stomach cancer	5.07e-05	0.00039	CcSEcCtD
Carvedilol—Infection—Doxorubicin—stomach cancer	5.06e-05	0.000389	CcSEcCtD
Carvedilol—Pain—Methotrexate—stomach cancer	5.03e-05	0.000387	CcSEcCtD
Carvedilol—Vomiting—Capecitabine—stomach cancer	5.02e-05	0.000386	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Epirubicin—stomach cancer	5.01e-05	0.000386	CcSEcCtD
Carvedilol—Shock—Doxorubicin—stomach cancer	5.01e-05	0.000385	CcSEcCtD
Carvedilol—Thrombocytopenia—Doxorubicin—stomach cancer	4.98e-05	0.000384	CcSEcCtD
Carvedilol—Rash—Capecitabine—stomach cancer	4.98e-05	0.000383	CcSEcCtD
Carvedilol—Insomnia—Epirubicin—stomach cancer	4.97e-05	0.000383	CcSEcCtD
Carvedilol—Dermatitis—Capecitabine—stomach cancer	4.97e-05	0.000383	CcSEcCtD
Carvedilol—Tachycardia—Doxorubicin—stomach cancer	4.97e-05	0.000382	CcSEcCtD
Carvedilol—Headache—Capecitabine—stomach cancer	4.95e-05	0.000381	CcSEcCtD
Carvedilol—Skin disorder—Doxorubicin—stomach cancer	4.94e-05	0.00038	CcSEcCtD
Carvedilol—Paraesthesia—Epirubicin—stomach cancer	4.94e-05	0.00038	CcSEcCtD
Carvedilol—Hyperhidrosis—Doxorubicin—stomach cancer	4.92e-05	0.000379	CcSEcCtD
Carvedilol—Dyspnoea—Epirubicin—stomach cancer	4.9e-05	0.000377	CcSEcCtD
Carvedilol—Somnolence—Epirubicin—stomach cancer	4.89e-05	0.000376	CcSEcCtD
Carvedilol—Anorexia—Doxorubicin—stomach cancer	4.85e-05	0.000373	CcSEcCtD
Carvedilol—Nausea—Docetaxel—stomach cancer	4.84e-05	0.000373	CcSEcCtD
Carvedilol—Feeling abnormal—Methotrexate—stomach cancer	4.84e-05	0.000373	CcSEcCtD
Carvedilol—Dyspepsia—Epirubicin—stomach cancer	4.84e-05	0.000373	CcSEcCtD
Carvedilol—Gastrointestinal pain—Methotrexate—stomach cancer	4.81e-05	0.00037	CcSEcCtD
Carvedilol—Decreased appetite—Epirubicin—stomach cancer	4.78e-05	0.000368	CcSEcCtD
Carvedilol—Hypotension—Doxorubicin—stomach cancer	4.76e-05	0.000366	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Epirubicin—stomach cancer	4.75e-05	0.000365	CcSEcCtD
Carvedilol—Fatigue—Epirubicin—stomach cancer	4.74e-05	0.000365	CcSEcCtD
Carvedilol—Pain—Epirubicin—stomach cancer	4.7e-05	0.000362	CcSEcCtD
Carvedilol—Constipation—Epirubicin—stomach cancer	4.7e-05	0.000362	CcSEcCtD
Carvedilol—Nausea—Capecitabine—stomach cancer	4.69e-05	0.000361	CcSEcCtD
Carvedilol—Urticaria—Methotrexate—stomach cancer	4.67e-05	0.000359	CcSEcCtD
Carvedilol—Abdominal pain—Methotrexate—stomach cancer	4.65e-05	0.000358	CcSEcCtD
Carvedilol—Body temperature increased—Methotrexate—stomach cancer	4.65e-05	0.000358	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.64e-05	0.000357	CcSEcCtD
Carvedilol—Insomnia—Doxorubicin—stomach cancer	4.6e-05	0.000354	CcSEcCtD
Carvedilol—Paraesthesia—Doxorubicin—stomach cancer	4.57e-05	0.000352	CcSEcCtD
Carvedilol—Dyspnoea—Doxorubicin—stomach cancer	4.54e-05	0.000349	CcSEcCtD
Carvedilol—Feeling abnormal—Epirubicin—stomach cancer	4.53e-05	0.000349	CcSEcCtD
Carvedilol—Somnolence—Doxorubicin—stomach cancer	4.52e-05	0.000348	CcSEcCtD
Carvedilol—Gastrointestinal pain—Epirubicin—stomach cancer	4.5e-05	0.000346	CcSEcCtD
Carvedilol—Dyspepsia—Doxorubicin—stomach cancer	4.48e-05	0.000345	CcSEcCtD
Carvedilol—Decreased appetite—Doxorubicin—stomach cancer	4.42e-05	0.00034	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Doxorubicin—stomach cancer	4.39e-05	0.000338	CcSEcCtD
Carvedilol—Fatigue—Doxorubicin—stomach cancer	4.39e-05	0.000338	CcSEcCtD
Carvedilol—Urticaria—Epirubicin—stomach cancer	4.37e-05	0.000336	CcSEcCtD
Carvedilol—Constipation—Doxorubicin—stomach cancer	4.35e-05	0.000335	CcSEcCtD
Carvedilol—Pain—Doxorubicin—stomach cancer	4.35e-05	0.000335	CcSEcCtD
Carvedilol—Abdominal pain—Epirubicin—stomach cancer	4.35e-05	0.000335	CcSEcCtD
Carvedilol—Body temperature increased—Epirubicin—stomach cancer	4.35e-05	0.000335	CcSEcCtD
Carvedilol—Hypersensitivity—Methotrexate—stomach cancer	4.33e-05	0.000333	CcSEcCtD
Carvedilol—Asthenia—Methotrexate—stomach cancer	4.22e-05	0.000325	CcSEcCtD
Carvedilol—Feeling abnormal—Doxorubicin—stomach cancer	4.19e-05	0.000323	CcSEcCtD
Carvedilol—Gastrointestinal pain—Doxorubicin—stomach cancer	4.16e-05	0.00032	CcSEcCtD
Carvedilol—Pruritus—Methotrexate—stomach cancer	4.16e-05	0.00032	CcSEcCtD
Carvedilol—Hypersensitivity—Epirubicin—stomach cancer	4.05e-05	0.000312	CcSEcCtD
Carvedilol—Urticaria—Doxorubicin—stomach cancer	4.04e-05	0.000311	CcSEcCtD
Carvedilol—Abdominal pain—Doxorubicin—stomach cancer	4.02e-05	0.00031	CcSEcCtD
Carvedilol—Body temperature increased—Doxorubicin—stomach cancer	4.02e-05	0.00031	CcSEcCtD
Carvedilol—Diarrhoea—Methotrexate—stomach cancer	4.02e-05	0.000309	CcSEcCtD
Carvedilol—Asthenia—Epirubicin—stomach cancer	3.95e-05	0.000304	CcSEcCtD
Carvedilol—Pruritus—Epirubicin—stomach cancer	3.89e-05	0.000299	CcSEcCtD
Carvedilol—Dizziness—Methotrexate—stomach cancer	3.89e-05	0.000299	CcSEcCtD
Carvedilol—Diarrhoea—Epirubicin—stomach cancer	3.76e-05	0.00029	CcSEcCtD
Carvedilol—Hypersensitivity—Doxorubicin—stomach cancer	3.75e-05	0.000289	CcSEcCtD
Carvedilol—Vomiting—Methotrexate—stomach cancer	3.74e-05	0.000288	CcSEcCtD
Carvedilol—Rash—Methotrexate—stomach cancer	3.71e-05	0.000285	CcSEcCtD
Carvedilol—Dermatitis—Methotrexate—stomach cancer	3.7e-05	0.000285	CcSEcCtD
Carvedilol—Headache—Methotrexate—stomach cancer	3.68e-05	0.000283	CcSEcCtD
Carvedilol—Asthenia—Doxorubicin—stomach cancer	3.65e-05	0.000281	CcSEcCtD
Carvedilol—Dizziness—Epirubicin—stomach cancer	3.64e-05	0.00028	CcSEcCtD
Carvedilol—Pruritus—Doxorubicin—stomach cancer	3.6e-05	0.000277	CcSEcCtD
Carvedilol—Vomiting—Epirubicin—stomach cancer	3.5e-05	0.000269	CcSEcCtD
Carvedilol—Nausea—Methotrexate—stomach cancer	3.49e-05	0.000269	CcSEcCtD
Carvedilol—Diarrhoea—Doxorubicin—stomach cancer	3.48e-05	0.000268	CcSEcCtD
Carvedilol—Rash—Epirubicin—stomach cancer	3.47e-05	0.000267	CcSEcCtD
Carvedilol—Dermatitis—Epirubicin—stomach cancer	3.46e-05	0.000267	CcSEcCtD
Carvedilol—Headache—Epirubicin—stomach cancer	3.45e-05	0.000265	CcSEcCtD
Carvedilol—Dizziness—Doxorubicin—stomach cancer	3.37e-05	0.000259	CcSEcCtD
Carvedilol—Nausea—Epirubicin—stomach cancer	3.27e-05	0.000251	CcSEcCtD
Carvedilol—Vomiting—Doxorubicin—stomach cancer	3.24e-05	0.000249	CcSEcCtD
Carvedilol—Rash—Doxorubicin—stomach cancer	3.21e-05	0.000247	CcSEcCtD
Carvedilol—Dermatitis—Doxorubicin—stomach cancer	3.21e-05	0.000247	CcSEcCtD
Carvedilol—Headache—Doxorubicin—stomach cancer	3.19e-05	0.000245	CcSEcCtD
Carvedilol—Nausea—Doxorubicin—stomach cancer	3.02e-05	0.000233	CcSEcCtD
Carvedilol—CYP1A2—Metabolism—PPP2R1A—stomach cancer	1.6e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—MTHFR—stomach cancer	1.6e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ERCC2—stomach cancer	1.59e-06	1.04e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—PIK3CA—stomach cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MMP9—stomach cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CXCL8—stomach cancer	1.58e-06	1.03e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CDKN1A—stomach cancer	1.57e-06	1.03e-05	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—HRAS—stomach cancer	1.57e-06	1.03e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTP1—stomach cancer	1.57e-06	1.02e-05	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—HRAS—stomach cancer	1.57e-06	1.02e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—HRAS—stomach cancer	1.57e-06	1.02e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	1.56e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—PIK3CA—stomach cancer	1.56e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—MAPK3—stomach cancer	1.56e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—ERBB2—stomach cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—HMOX1—stomach cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—ALB—stomach cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	1.55e-06	1.01e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CDKN1B—stomach cancer	1.54e-06	1e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MAPK8—stomach cancer	1.54e-06	1e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—ERBB2—stomach cancer	1.53e-06	9.96e-06	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	1.52e-06	9.92e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	1.52e-06	9.91e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	1.52e-06	9.91e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—IL6—stomach cancer	1.51e-06	9.86e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6R—stomach cancer	1.51e-06	9.83e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—MTHFR—stomach cancer	1.51e-06	9.82e-06	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—IL6—stomach cancer	1.51e-06	9.81e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	1.5e-06	9.81e-06	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—IL6—stomach cancer	1.5e-06	9.79e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—IL6—stomach cancer	1.5e-06	9.77e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—MTHFR—stomach cancer	1.49e-06	9.73e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CCND1—stomach cancer	1.48e-06	9.66e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—NOS3—stomach cancer	1.48e-06	9.65e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—MAPK1—stomach cancer	1.48e-06	9.65e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—IL6—stomach cancer	1.48e-06	9.65e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—EGFR—stomach cancer	1.48e-06	9.65e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—JUN—stomach cancer	1.48e-06	9.64e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—stomach cancer	1.47e-06	9.61e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CAV1—stomach cancer	1.47e-06	9.61e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CXCL8—stomach cancer	1.47e-06	9.6e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—APOA1—stomach cancer	1.47e-06	9.59e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CCND1—stomach cancer	1.47e-06	9.57e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RHOA—stomach cancer	1.47e-06	9.56e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—JUN—stomach cancer	1.47e-06	9.55e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—HRAS—stomach cancer	1.46e-06	9.54e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—TYMS—stomach cancer	1.46e-06	9.52e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—ALB—stomach cancer	1.46e-06	9.51e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CD44—stomach cancer	1.45e-06	9.48e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—NOS3—stomach cancer	1.45e-06	9.46e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CCND1—stomach cancer	1.45e-06	9.45e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CXCL8—stomach cancer	1.45e-06	9.45e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—JUN—stomach cancer	1.45e-06	9.43e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—GSTM1—stomach cancer	1.44e-06	9.41e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—HRAS—stomach cancer	1.44e-06	9.38e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MMP9—stomach cancer	1.44e-06	9.38e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CDKN1B—stomach cancer	1.44e-06	9.37e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	1.43e-06	9.35e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MMP9—stomach cancer	1.43e-06	9.29e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CDKN1A—stomach cancer	1.42e-06	9.26e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—VEGFA—stomach cancer	1.42e-06	9.24e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CDKN1B—stomach cancer	1.42e-06	9.22e-06	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—PIK3CA—stomach cancer	1.41e-06	9.22e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SERPINE1—stomach cancer	1.41e-06	9.21e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MMP9—stomach cancer	1.41e-06	9.17e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—STAT3—stomach cancer	1.4e-06	9.15e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	1.4e-06	9.14e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—IL6—stomach cancer	1.4e-06	9.13e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	1.4e-06	9.12e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—KRAS—stomach cancer	1.4e-06	9.11e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—NOS3—stomach cancer	1.4e-06	9.1e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CAV1—stomach cancer	1.39e-06	9.06e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MAPK8—stomach cancer	1.39e-06	9.04e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—APOA1—stomach cancer	1.39e-06	9.04e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	1.38e-06	9.01e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—IL6—stomach cancer	1.38e-06	8.98e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CAV1—stomach cancer	1.38e-06	8.98e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—APOA1—stomach cancer	1.37e-06	8.96e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CCND1—stomach cancer	1.37e-06	8.94e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	1.37e-06	8.92e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—JUN—stomach cancer	1.37e-06	8.92e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RHOA—stomach cancer	1.36e-06	8.88e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ERCC2—stomach cancer	1.36e-06	8.85e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	1.36e-06	8.85e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—stomach cancer	1.35e-06	8.83e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CCND1—stomach cancer	1.35e-06	8.8e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—NOS3—stomach cancer	1.35e-06	8.79e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—JUN—stomach cancer	1.35e-06	8.78e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MAPK3—stomach cancer	1.34e-06	8.74e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MMP9—stomach cancer	1.33e-06	8.68e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CDKN1A—stomach cancer	1.33e-06	8.65e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.32e-06	8.58e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MMP9—stomach cancer	1.31e-06	8.54e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CDKN1A—stomach cancer	1.31e-06	8.51e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MYC—stomach cancer	1.3e-06	8.5e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARG—stomach cancer	1.3e-06	8.45e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MAPK8—stomach cancer	1.3e-06	8.44e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	1.29e-06	8.42e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	1.29e-06	8.39e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—PIK3CA—stomach cancer	1.28e-06	8.37e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—VEGFA—stomach cancer	1.28e-06	8.35e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—STAT3—stomach cancer	1.28e-06	8.34e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	1.28e-06	8.34e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—stomach cancer	1.28e-06	8.32e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—MAPK1—stomach cancer	1.28e-06	8.32e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—MTHFR—stomach cancer	1.28e-06	8.32e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—EGFR—stomach cancer	1.28e-06	8.32e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MAPK8—stomach cancer	1.27e-06	8.31e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—STAT3—stomach cancer	1.27e-06	8.26e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	1.26e-06	8.24e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—ERBB2—stomach cancer	1.26e-06	8.22e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	1.26e-06	8.19e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—STAT3—stomach cancer	1.25e-06	8.16e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPP2R1A—stomach cancer	1.24e-06	8.06e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—IL6—stomach cancer	1.22e-06	7.98e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	1.22e-06	7.97e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARG—stomach cancer	1.22e-06	7.96e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTP1—stomach cancer	1.21e-06	7.91e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MAPK3—stomach cancer	1.21e-06	7.89e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARG—stomach cancer	1.21e-06	7.89e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—KRAS—stomach cancer	1.21e-06	7.86e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CCND1—stomach cancer	1.2e-06	7.82e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—JUN—stomach cancer	1.2e-06	7.8e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—HMOX1—stomach cancer	1.2e-06	7.8e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL8—stomach cancer	1.2e-06	7.8e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—VEGFA—stomach cancer	1.2e-06	7.8e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	1.2e-06	7.79e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MYC—stomach cancer	1.19e-06	7.75e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—HRAS—stomach cancer	1.19e-06	7.75e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—STAT3—stomach cancer	1.18e-06	7.72e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MYC—stomach cancer	1.18e-06	7.68e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CAV1—stomach cancer	1.18e-06	7.67e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—VEGFA—stomach cancer	1.18e-06	7.67e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—APOA1—stomach cancer	1.17e-06	7.66e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CDKN1B—stomach cancer	1.17e-06	7.61e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—ALB—stomach cancer	1.17e-06	7.6e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—STAT3—stomach cancer	1.17e-06	7.6e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MMP9—stomach cancer	1.16e-06	7.59e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	1.16e-06	7.58e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MYC—stomach cancer	1.16e-06	7.58e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—EGFR—stomach cancer	1.16e-06	7.58e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	1.16e-06	7.56e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—MAPK1—stomach cancer	1.15e-06	7.51e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—EGFR—stomach cancer	1.15e-06	7.51e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	1.14e-06	7.42e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—EGFR—stomach cancer	1.14e-06	7.41e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—IL6—stomach cancer	1.14e-06	7.41e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	1.13e-06	7.38e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MAPK3—stomach cancer	1.13e-06	7.37e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—TYMS—stomach cancer	1.13e-06	7.35e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.12e-06	7.33e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PIK3CA—stomach cancer	1.12e-06	7.28e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—NOS3—stomach cancer	1.12e-06	7.27e-06	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PIK3CA—stomach cancer	1.11e-06	7.27e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—GSTM1—stomach cancer	1.11e-06	7.26e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CCND1—stomach cancer	1.11e-06	7.26e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MAPK3—stomach cancer	1.11e-06	7.26e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—JUN—stomach cancer	1.11e-06	7.25e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—PIK3CA—stomach cancer	1.11e-06	7.22e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MYC—stomach cancer	1.1e-06	7.17e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—KRAS—stomach cancer	1.1e-06	7.16e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—ALB—stomach cancer	1.1e-06	7.16e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—ALB—stomach cancer	1.09e-06	7.1e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—KRAS—stomach cancer	1.09e-06	7.09e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MYC—stomach cancer	1.08e-06	7.06e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MMP9—stomach cancer	1.08e-06	7.05e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CDKN1A—stomach cancer	1.08e-06	7.03e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—MAPK1—stomach cancer	1.08e-06	7.02e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—EGFR—stomach cancer	1.08e-06	7.02e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—KRAS—stomach cancer	1.07e-06	7e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—stomach cancer	1.07e-06	6.98e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—MAPK1—stomach cancer	1.06e-06	6.91e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—EGFR—stomach cancer	1.06e-06	6.9e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MAPK8—stomach cancer	1.05e-06	6.86e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—NOS3—stomach cancer	1.05e-06	6.85e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ERCC2—stomach cancer	1.05e-06	6.83e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	1.05e-06	6.81e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—NOS3—stomach cancer	1.04e-06	6.79e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—STAT3—stomach cancer	1.04e-06	6.75e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARG—stomach cancer	1.03e-06	6.75e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—HRAS—stomach cancer	1.02e-06	6.68e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—stomach cancer	1.02e-06	6.65e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—KRAS—stomach cancer	1.02e-06	6.63e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	1.01e-06	6.58e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—KRAS—stomach cancer	1e-06	6.52e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—PIK3CA—stomach cancer	1e-06	6.52e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	9.89e-07	6.45e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	9.87e-07	6.43e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—MTHFR—stomach cancer	9.85e-07	6.42e-06	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—IL6—stomach cancer	9.81e-07	6.39e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—stomach cancer	9.76e-07	6.36e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—VEGFA—stomach cancer	9.71e-07	6.33e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—stomach cancer	9.67e-07	6.31e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MYC—stomach cancer	9.62e-07	6.27e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—STAT3—stomach cancer	9.62e-07	6.27e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—stomach cancer	9.61e-07	6.26e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—stomach cancer	9.55e-07	6.23e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—stomach cancer	9.53e-07	6.21e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	9.41e-07	6.13e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—EGFR—stomach cancer	9.41e-07	6.13e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—PIK3CA—stomach cancer	9.34e-07	6.09e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—HRAS—stomach cancer	9.34e-07	6.09e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—ALB—stomach cancer	9.31e-07	6.07e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—HRAS—stomach cancer	9.25e-07	6.03e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—PIK3CA—stomach cancer	9.19e-07	5.99e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MAPK3—stomach cancer	9.19e-07	5.99e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—HRAS—stomach cancer	9.13e-07	5.95e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CAV1—stomach cancer	9.09e-07	5.92e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PIK3CA—stomach cancer	9.07e-07	5.91e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—APOA1—stomach cancer	9.06e-07	5.91e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—stomach cancer	9.04e-07	5.89e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MYC—stomach cancer	8.94e-07	5.83e-06	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—IL6—stomach cancer	8.94e-07	5.82e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—NOS3—stomach cancer	8.9e-07	5.8e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—stomach cancer	8.89e-07	5.8e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—KRAS—stomach cancer	8.89e-07	5.79e-06	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—IL6—stomach cancer	8.85e-07	5.77e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—MAPK1—stomach cancer	8.74e-07	5.7e-06	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—IL6—stomach cancer	8.74e-07	5.7e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—EGFR—stomach cancer	8.74e-07	5.7e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—HRAS—stomach cancer	8.64e-07	5.63e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—HRAS—stomach cancer	8.51e-07	5.54e-06	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PIK3CA—stomach cancer	8.33e-07	5.43e-06	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—IL6—stomach cancer	8.27e-07	5.39e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—KRAS—stomach cancer	8.26e-07	5.38e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	8.17e-07	5.32e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—stomach cancer	8.14e-07	5.31e-06	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—IL6—stomach cancer	8.14e-07	5.31e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARG—stomach cancer	7.99e-07	5.21e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—stomach cancer	7.9e-07	5.15e-06	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PIK3CA—stomach cancer	7.86e-07	5.12e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—PIK3CA—stomach cancer	7.59e-07	4.95e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—HRAS—stomach cancer	7.55e-07	4.92e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—stomach cancer	7.34e-07	4.78e-06	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—IL6—stomach cancer	7.23e-07	4.71e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—ALB—stomach cancer	7.18e-07	4.68e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—HRAS—stomach cancer	7.02e-07	4.58e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—NOS3—stomach cancer	6.87e-07	4.48e-06	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—IL6—stomach cancer	6.72e-07	4.38e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—stomach cancer	6.28e-07	4.1e-06	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PIK3CA—stomach cancer	6.27e-07	4.09e-06	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PIK3CA—stomach cancer	5.91e-07	3.85e-06	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PIK3CA—stomach cancer	5.86e-07	3.82e-06	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PIK3CA—stomach cancer	5.01e-07	3.26e-06	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.87e-07	2.52e-06	CbGpPWpGaD
